A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors
Jacobio Pharmaceuticals Co., Ltd.
Jacobio Pharmaceuticals Co., Ltd.
Seagen Inc.
Incyte Corporation
Allist Pharmaceuticals, Inc.
Bayer
Jacobio Pharmaceuticals Co., Ltd.
Novartis
AstraZeneca
Maria Sklodowska-Curie National Research Institute of Oncology
Traws Pharma, Inc.
OHSU Knight Cancer Institute
Hoag Memorial Hospital Presbyterian